Hugo has founded several healthcare and biotech services businesses including DrugDev (acquired by IQVIA) MediGuard (owned by IQVIA), Health Research Solutions (acquired by Quintiles, now IQVIA), and MedSeed (acquired by eHealthcare Asia).
Hugo served as full-time Executive Chairman, Product Lead and co-founder at DrugDev from 2012-2017. Previously, Hugo served as Vice President at Quintiles (now IQVIA) from 2002 to 2011.
James has a wealth of NHS facing commercial experience, having co-founded Zesty Limited in 2012, a multi award winning UK digital health company. Prior to Zesty, James was Ecommerce Director at EE, leading the digital teams at both Orange and T-Mobile during the merger and subsequent launch of EE.
As head of ecommerce at the Shop Direct Group, James led the transition from catalogue to online shopping, creating one of the largest online retail organisations in the UK.
Chris has nearly 40 years’ experience in software, healthcare, and legal matters. He joined EMIS Group plc in 1999 holding senior roles including Chief Administrative Officer and, from 2013, Chief Executive Officer. Currently he serves on a number of digital health related private company boards and is a Digital Health Venture Partner for GM&C Life Sciences Fund at Catapult Ventures Group.
Chris is a solicitor (non-practising). Formerly an Associate of the Chartered Institute of Patent Agents and member of the Law Society of England and Wales and Fellow of the Chartered Management Institute he remains a member of the Society for Computers and Law. He holds an LLB (Hons) and qualified as a solicitor (with distinction).
Jane is Executive Chair of Diffblue Ltd and a non-executive director of The Sensible Code Company Limited. She also serves as an advisor for tech start-ups.
Previously she was CEO of Canonical for 7 years, which followed a 7 year period as COO of Canonical. With experience in the US, Japan and the UK, she has spent her entire career in software engineering and IT management, starting as a software developer and rising through various leadership roles. She holds a BS from Haverford College, an MS from Vanderbilt University, and an MBA from Oxford University.
Leslie-Ann is a chartered accountant with a diverse background and extensive international experience, having served in both executive and non-executive roles in publicly listed media and professional services companies.
Leslie-Ann is currently Non-Executive Director and Chair of the Audit Committee for Learning Technologies Group plc and Non-Executive Director at Bloomsbury Publishing plc, where she is a member of the Audit and Remuneration Committees. Previously, Leslie-Ann was a Non-Executive Director of the German listed company ZEAL Networks SE where she was Vice Chair of the Supervisory Board and Chaired the Audit Committee. Until May 2018 she was a Non-Executive Director and Chair of the Audit Committee of the London listed publisher Quarto Group, Inc.
From 2010 to 2012 she was Chief Financial Officer of Go Industry Dove Bid plc, leading its successful sale in 2012. Between 2007 and 2010 Leslie-Ann was an adviser to Marwyn Investment Management. Prior to that, she served as Chief Financial Officer of Metal Bulletin plc. Leslie-Ann also held senior finance leadership roles at Universal Pictures, Polygram Music, EMI Music and Warner Communications Inc.
In addition to his role at Induction, Andy is chairman of Docly AB and a non-executive director at Logex Group. His most recent full time role was CEO of NHS Digital, the government body responsible for technology and data for the NHS.
Prior to that, his career was in the technology industry, holding a wide variety of senior roles in IBM, Alcatel-Lucent and CSC. He holds an MA in mathematics and engineering from Cambridge University.